The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.
Authors: Spellberg B (AUTHOR), Ibrahim AS (AUTHOR), Chin-Hong PV (AUTHOR), Kontoyiannis DP (AUTHOR), Morris MI (AUTHOR), Perfect JR (AUTHOR), Fredricks D (AUTHOR), Brass EP (AUTHOR), Spellberg, Brad1 (AUTHOR), Ibrahim, Ashraf S (AUTHOR), Chin-Hong, Peter V (AUTHOR), Kontoyiannis, Dimitrios P (AUTHOR), Morris, Michele I (AUTHOR), Perfect, John R (AUTHOR), Fredricks, David (AUTHOR), Brass, Eric P (AUTHOR)
Source: Journal of Antimicrobial Chemotherapy (JAC). Mar2012, Vol. 67 Issue 3, p715-722. 8p.
Database: Environment Complete
Description
ISSN:03057453
DOI:10.1093/jac/dkr375